On July 15th, 2022 AMP held its second Annual Molecular Pathology Economics Summit. Though it was delayed for two years due to the COVID-19 pandemic, this event was a follow up of the first Summit held in 2019. This one-day event brought together 67 attendees ranging from patient advocacy groups, pharmaceutical companies, diagnostic manufacturers, clinical laboratories, as well as trade and professional associations. Robust, candid discussions between stakeholders explored the unique challenges they face, barriers to patient access to molecular diagnostic testing, as well as potential solutions and/or novel approaches to overcoming these barriers, with the goal of identifying shared policy agendas for the participating stakeholders.  Furthermore, AMP held its first ever Innovation Lab where stakeholders were given the opportunity to present their work on expanding patient access to molecular diagnostics as well as build partnerships with other attendees to collaborate on action items to improve patient access in the future.

---

Notify Me

If you would like to be notified as more information becomes available, please complete this form.

---

Note Regarding the Ongoing COVID-19 Pandemic:

The safety of our participants is our number one concern. This event is currently being planned as an in-person event. This event will comply with all current DC COVID-19 regulations, and we will keep registrants updated with the full requirements. 

---

Facilitator

 

Clifford Goodman, PhD, has 35 years of experience in such areas as health technology assessment, evidence-based health care, clinical practice guidelines, health economics, and studies pertaining to health care innovation, regulation, and payment.  He directs studies and projects for an international range of government agencies; pharmaceutical, biotechnology, and medical device companies; health care provider institutions; and professional, industry, and patient advocacy groups.  His recent work has involved such areas as chronic disease, infectious disease, cancer, rare diseases, diagnostic testing, gene therapy, pharmacogenomics, personalized medicine, biosimilars, value frameworks, value-based contracting, social determinants of health, and applications of real-world data.  Dr. Goodman is an internationally recognized health policy issues moderator and facilitator of expert panels, advisory boards, workshops, and focus groups. 

Dr. Goodman served as chair of the Medicare Evidence Development & Coverage Advisory Committee (MEDCAC, 2009-12) for the Centers for Medicare and Medicaid Services (CMS).  He served as president of the professional society, Health Technology Assessment international (HTAi, 2011-13), and is a Fellow of the American Institute for Medical and Biological Engineering.  In 2022, he received the David Banta Distinguished Career Award in Health Technology Assessment from HTAi.  He earned a PhD from The Wharton School of the University of Pennsylvania, a Master of Science from The Georgia Institute of Technology, and a Bachelor of Arts from Cornell University. 

After 27 years, including as Senior Vice President, Dr. Goodman recently retired from The Lewin Group and is an independent consultant in health care technology and policy.

 

---

 

Preview and Preliminary Agenda of the 2023 Summit

The agenda for this event is still to be determined! If you want a an idea of the potential topics and format please check out the 2022 Summit Agenda.

Please reach out to us at policy@amp.org if you are interested in getting updates about the 2023 Summit.

 

---

Summit Planning Committee

AMP Economic Affairs Committee Chair
Samuel K. Caughron, MD
MAWD Pathology Group, P.A.

AMP Economic Affairs Committee Vice Chair: Coverage Decisions
Pranil Chandra, DO
PathGroup, LLC

AMP Economic Affairs Committee Vice Chair: New Codes and Pricing
Jay Patel, MD
ARUP Laboratories

AMP Economic Affairs Committee Member
Erin Graf, BS, PhD
Mayo Clinic

AMP Economic Affairs Committee Member
Keyur Patel, MD, PhD
Anderson Cancer Center

AMP Economic Affairs Committee Member
Victoria M. Pratt, PhD, FACMG
Agena Bioscience

AMP Economic Affairs Committee Member
Ester Stein, BS, MBA
Abbott

AMP Economic Affairs Committee Member
Eric Vail, MS, MD
Cedars-Sinai Medical Center

AMP Economic Affairs Committee Member
Heather E. Williams, MS, PhD
King's College Hospital/Viapath

 

Government Relations Consultants: iPolicy Solutions
Jennifer Leib, ScM, CGC

Megan Anderson Brooks, PhD

Lindsey Trischler, MPAP
 

Government Relations Consultants: CRD Associates
Erika Miller, JD

Michaela Hollis, MPH

Stefanie Rinehart, JD, MPH

---

Registration Information

Registration pricing is for a single individual. Please select your registration type based on your current organization. To register for this event 1.) click Register (above) 2.) either login using your AMP credentials or scroll down to create a new account.

IMPORTANT: Participation is limited and we encourage you to register and reserve your space as soon as possible. We anticipate that this event will sell-out. 

Registration Type	Advanced Registration (Until August 13th)	Regular/On-Site (August 14th Onward)
Associations & Patient Advocacy Groups*	First Attendee from your organization is FREE	First Attendee from your organization is FREE
Non-Profit Organizations	$375 USD	$400 USD
For-Profit Organizations**	$950 USD	$1,150 USD